Alnylam Pharmaceuticals Inc (ALNY)
242.20
-3.30
(-1.34%)
USD |
NASDAQ |
Dec 23, 16:00
242.20
0.00 (0.00%)
After-Hours: 19:23
Alnylam Pharmaceuticals Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median